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Plants containing pyrrolizidine alkaloids (PAs) are widespread throughout the world and
are the most common poisonous plants affecting livestock, wildlife, and humans. PAs
require metabolic activation to form reactive dehydropyrrolizidine alkaloids (dehydro-PAs)
that are capable of alkylating cellular DNA and proteins, form (±)-6,7-dihydro-7-hydroxy-1-
hydroxymethyl-5H-pyrrolizine (DHP)-DNA and DHP-protein adducts, and lead to cytotox-
icity, genotoxicity, and tumorigenicity. In this study, we determined that the metabolism of
riddelliine and monocrotaline by human and rat liver microsomes in the presence of N-
acetylcysteine both produced 7-N-acetylcysteine-DHP (7-NAC-DHP) and DHP. Reactions of
7-NAC-DHP with 20-deoxyguanosine (dG), 20-deoxyadenosine (dA), and calf thymus DNA in
aqueous solution followed by enzymatic hydrolysis yielded DHP-dG and/or DHP-dA ad-
ducts. These results indicate that 7-NAC-DHP is a reactive metabolite that can lead to DNA
adduct formation.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
To date, more than 660 pyrrolizidine alkaloids (PAs) and PA N-
oxides have been identified in over 6000 plant species distrib-
uted worldwide. About half of these phytochemicals contain a
C2eC3 double bond at the necine base and are hepatotoxic;
many of them are genotoxic and tumorigenic in experimental
animals [1e7]. It has long been established that PA-containing
plants are probably the most common poisonous plants
affecting livestock, wildlife, and humans [1,6].
PAs are biologically inactive and require metabolism to
exert toxicity. Upon metabolism, PAs generater Toxicological Research,
. Fu).
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).dehydropyrrolizidine alkaloids (dehydro-PAs) as the primary
reactive pyrrolic metabolites [3,6]. Dehydro-PAs are highly
unstable, they can be readily hydrolyzed into (±)-6,7-dihydro-
7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP), and
alkylate cellular DNA and proteins to produce DHP-DNA and
DHP-protein adducts, leading to cytotoxicity, genotoxicity,
and tumorigenicity (Fig. 1) [1,6].
We recently determined that PA-induced liver tumors in
rats were mediated by a set of four DHP-DNA adducts, i.e., a
pair of epimers of 7-hydroxy-9-(deoxyguanosin-N2-yl)dehy-
drosupinidine adducts (designated as DHP-dG-3 and DHP-dG-
4), and a pair of epimers of 7-hydroxy-9-(deoxyadenosin-N6-
yl)dehydrosupinidine adducts (designated as DHP-dA-3 andU.S. Food and Drug Administration, Jefferson, Arkansas 72079,
hed by Elsevier Taiwan LLC. This is an open access article under the CC
Figure 1 e Structures of PAs, dehydro-PAs, DHP, DHP-dG-1,
DHP-dG-2, DHP-dG-3, DHP-dG-4, DHP-dA-1, DHP-dA-2,
DHP-dA-3, and DHP-dA-4 adducts. dA ¼ 2′-
deoxyadenosine, dG ¼ 2′-deoxyguanosine, DHP¼ (±)-6,7-
dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine,
PA ¼ pyrrolizidine alkaloids.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4 683DHP-dA-4) (Fig. 1) [8]. Based on this and previous findings in
our laboratory [2,9e18], we proposed that DHP-dG-3, DHP-dG-
4, DHP-dA-3, and DHP-dA-4 adducts are biomarkers of PA
exposure and potential biomarkers of PA-inducedcarcinogenicity [8]. In addition, a pair of epimers of 7-(deoxy-
guanosin-N2-yl)dehydrosupinidine adducts (designated as
DHP-dG-1 and DHP-dG-2 adducts) and a pair of epimers of 7-
(deoxyadenosin-N6-yl)dehydrosupinidine adducts (desig-
nated as DHP-dA-1 and DHP-dA-2 adducts) were also pro-
duced in vitro (Fig. 1) [8,10,19].
Dehydro-PAs have a very short half-life in aqueous sys-
tems, only around 0.31e5.36 seconds [20], and thusmay not be
the principal reactive metabolites to bind to cellular DNA
leading to genotoxicity and carcinogenicity. Consequently,
there may be other reactive metabolites that can also bind to
cellular DNA to initiate cytotoxicity, genotoxicity, and carci-
nogenicity [6].
7-Glutathionyl-(±)-6,7-dihydro-1-hydroxymethyl-5H-pyr-
rolizine (7-GS-DHP) is a metabolite formed in vivo and in vitro
[21e25]. We recently found that 7-GS-DHP can bind with calf
thymus DNA to form the eight above described DHPeDNA
adducts, e.g., DHP-dG-1, DHP-dG-2, DHP-dG-3, DHP-dG-4,
DHP-dA-1, DHP-dA-2, DHP-dA-3, and DHP-dA-4 adducts [26].
We have also found that 7-cysteine-DHP is a new metabolite
formed from themetabolism of riddelliine andmonocrotaline
by human and rat liver microsomes and can bind with calf
thymus DNA to form the same set of DHP-dG and DHP-dA
adducts [27]. These results suggest that both 7-GS-DHP and
7-cysteine-DHP are reactive metabolites that can lead to DNA
adduct formation.
Estep et al [28] reported that 7-N-acetylcysteine-DHP (7-
NAC-DHP) was detected in the urine of male Sprague-
Dawley rats administered 14C-monocrotaline or 14C-sen-
ecionine. They suggested that 7-NAC-DHP was formed in the
liver and excreted in the urine [28]. In the present study, we
determined that metabolism of monocrotaline and riddelliine
by human and rat liver microsomes in the presence of N-
acetylcysteine generated 7-NAC-DHP. We subsequently
determined that reaction of 7-NAC-DHP with 20-deoxy-
guanosine (dG), 20-deoxyadenosine (dA), and calf thymus DNA
generated DHP-dG and/or DHP-dA adducts. These results
suggest that, similar to 7-GS-DHP and 7-cysteine-DHP, 7-NAC-
DHP adduct can be a potential DNA reactive metabolite of PAs
and may potentially initiate liver tumors in rodents and
humans.2. Materials and methods
2.1. Chemicals
N-acetylcysteine, calf thymus DNA (sodium salt, Type I),
nuclease P1, micrococcal nuclease, spleen phosphodiesterase,
NADPH, 20-deoxyguanosine (dG), and 20-deoxyadenosine (dA)
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Dimethylformamide, acetonitrile, potassium carbonate,
chloroform, diethyl ether, and phosphate buffered salinewere
obtained from Fisher Scientific (Pittsburg, PA, USA). AX 1-X8
anion exchange resin was purchased from Bio-Rad (Hercules,
CA, USA). All solvents used were high performance liquid
chromatography (HPLC) grade.
Dehydromonocrotaline was synthesized by dehydrogena-
tion of monocrotaline in chloroform with o-chloranil, as pre-
viously described [19]. DHPwas obtained from themetabolism
Figure 2 e HPLC profiles of 7-NAC-DHP and DHP obtained from (A) organic synthesis; and from metabolism of riddelliine in
the presence of N-acetylcysteine by (B) male human liver microsomes; (C) male rat liver microsomes; and (D) male rat liver
microsomes without the addition of NADPH. DHP¼ (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine,
HPLC ¼ high performance liquid chromatography, NAC ¼ N-acetylcysteine.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4684of riddelliine by rat liver microsomes [27]. DHP-dG-1, DHP-dG-
2, DHP-dG-3, DHP-dG-4, DHP-dA-1, DHP-dA-2, DHP-dA-3, and
DHP-dA-4 adducts were synthesized as previously described
[10,19]. Isotopically labeled DHP-[15N5]dG and DHP-[
15N5,
13C10]
dA adducts, used as internal standards for quantitation of
DHP-dG and DHP-dA adducts by liquid chromatography-
tandem mass spectrometry (LC/MS/MS), were synthesized as
described previously [8,10].
Male human liver microsomes and male Fischer 344 rat
liver microsomes were purchased from Bioreclamation IVT
(Baltimore, MD, USA). DNA concentrations were determined
spectrophotometrically.2.2. Synthesis of 7-NAC-DHP adduct
N-acetylcysteine (125mg, 0.77mmol) dissolved in 5mL acetone
was added dropwise to a solution of dehydromonocrotaline
(200 mg, 0.62 mmol) in 20 mL acetone at ambient temperature.
The reaction mixture was stirred at ambient temperature for
2 hours, and then poured into 100 mL phosphate buffered sa-
line (0.1 M, pH ¼ 7.4). After the solvent was removed under
reduced pressure, the resulting residue was dissolved in 3 mL
0.005% formic acid and ammonia solution (pH 8), and loaded to
a C18 open column (20 g), first elutingwith 50mL 0.005% formic
acid and ammonia solution (pH 8) to remove the salts and N-
R
el
at
iv
e 
ab
un
da
nc
e
R
el
at
iv
e 
ab
un
da
nc
e
R
el
at
iv
e 
ab
un
da
nc
e
R
el
at
iv
e 
ab
un
da
nc
e
Figure 3 e Electrospray positive ion/product ion mass spectra of 7-NAC-DHP from (A) organic synthesis; and in the
chromatographic peak eluting at 28.85e29.25 minutes in Fig. 2 obtained from the results of the metabolism of riddelliine in
the presence of N-acetylcysteine by (B) male human liver microsomes; (C) male rat liver microsomes; and (D) male rat liver
microsomes without the addition of NADPH. The product ions of the [M e H2Oþ H]þm/z 281 were acquired with a collision
energy of 10 eV. DHP¼ (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC ¼ N-acetylcysteine.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4 685acetylcysteine, then with 100 mL 4% acetonitrile in 0.005%
formic acid and ammonia solution (pH 8) to collect the prod-
ucts. The 7-NAC-DHP adduct-containing fractions were
concentrated and purified by HPLC with the following condi-
tions: column (Phenomenex Luna (Phenomenex Inc., Torrance,
CA, USA) C18 (2), 250 mm  10 mm), flow rate (3 mL/min),
mobile phase (5% acetonitrile in 0.005% formic acid and
ammonia solution (pH 8), isocratic), monitored at 220 nm. This
resulted in a pure product identified as a pair of epimeric 7-
NAC-DHP in a nearly equal ratio. The product ion scan massspectrum had an [M e H2O þ H]þ ion at m/z 281 and charac-
teristic fragment ions at m/z 116e119 and m/z 150e152. The
structure was confirmed by 1H nuclear magnetic resonance
(NMR) spectral data. The 1H NMR spectral assignments of 7-
NAC-DHP adduct are as follows:
7-NAC-DHP. 1H NMR (500 MHz, D2O): d 2.50 (m, 1H, H6a),
2.98-2.88 (m, 1H, H6b), 3.05 (m, 1H, H20), 3.15 (m, 1H, H20), 3.62
(m, 1H, H10), 3.88 (m, 1H, H10), 3.92 (m, 1H, H5b), 4.02 (m, 1H,
H5a), 4.52e4.44 (m, 3H, H7, H9), 6.17 (d, J ¼ 2.6 Hz, 1H, H2), 6.62
(d, J ¼ 2.6 Hz, 1H, H3).
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Figure 4 e Electrospray positive ion/product ionmass spectra of DHP from (A) organic synthesis; and in the chromatographic
peak eluting at 25.3 minutes in Fig. 2 obtained from the metabolism of riddelliine in the presence of N-acetylcysteine by (B)
male human liver microsomes; (C) male rat liver microsomes; and (D) male rat liver microsomes in the absence of NADPH,
The product ions of the [M e H2O þ H]þ m/z 136 were acquired with a collision energy of 22 eV. DHP ¼ (±)-6,7-dihydro-7-
hydroxy-1-hydroxymethyl-5H-pyrrolizine.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 46862.3. Formation of 7-NAC-DHP from metabolism of
riddelliine and monocrotaline by human and rat liver
microsomes in the presence of N-acetylcysteine
The metabolism of riddelliine (or monocrotaline) by male
F344 rat microsomes in the presence of N-acetylcysteine was
conducted in a 1 mL incubation volume containing 100 mM
sodium phosphate buffer (pH 7.6), 5 mM magnesium chlo-
ride, 1 mM NADPH, 500 mM riddelliine (or monocrotaline),
2 mM N-acetylcysteine, and 1 mg of rat liver microsomalprotein at 37C for 60 minutes. After the incubation, the
mixture was centrifuged at 105,000 g for 30 minutes at 4C to
remove microsomal proteins. The supernatant was
collected, and aliquots of 50 mL were directly subjected to
HPLC-UV analysis. The metabolism of riddelliine and mon-
ocrotaline by male human liver microsomes was conducted
similarly.
The metabolism of riddelliine (or monocrotaline) by male
F344 rat microsomes in the presence of N-acetylcysteine, but
without the addition of NADPH, was also performed.
Figure 5 e HPLC profiles of 7-NAC-DHP and DHP from (A) organic synthesis; and from metabolism of monocrotaline in the
presence of N-acetylcysteine by (B) male human liver microsomes; and (C) male rat liver microsomes. DHP¼ (±)-6,7-
dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC ¼ N-acetylcysteine.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4 6872.4. Reaction of 7-N-acetylcyteine-DHP with dG and dA
Following the experimental conditions previously reported for
the reaction of 7-GS-DHP with dG [26], 1 mL of reaction
mixture containing 1 mM 7-NAC-DHP and 2 mM dG in 0.01%
formic acid and ammonia solution (pH 8) was kept at 37C
with shaking. The reaction products were monitored by HPLC
for 1, 3, and 5 days, respectively, with the following condi-
tions: Phenomenex Luna C18 (2) column, 250 mm  4.6 mm,
isocratic elutionwith 12% acetonitrile in water at a flow rate of
1 mL/min, monitored at 256 nm for DHP-dG and 220 nm for
DHP, respectively.
The reaction of 7-NAC-DHP with dA was similarly con-
ducted with the exceptions: monitored at 269 nm for DHP-dA,
and isocratic elution with 15% acetonitrile in water.
2.5. Reaction of 7-NAC-DHP with calf thymus DNA
A 1 mL of reaction mixture containing 500 mM 7-NAC-DHP and
1 mg calf thymus DNA in 0.01% formic acid and ammonia so-
lution (pH 8) was kept at 37C with shaking for 1, 3, and 5 days.
After the reaction, 100 mL aliquots of the reaction mixtures
(containing 100 mg DNA) were enzymatically hydrolyzed tonucleotides with micrococcal nuclease, spleen phosphodies-
terase, and nuclease P1 as previously described [26] before LC/
MS/MS analysis. Reactions were conducted in triplicate.
2.6. HPLC- electrospray-MS/MS analysis of metabolites
and reaction products
Liquid chromatography. A Finnigan Surveyor HPLC system
(ThermoFinnigan, San Jose, CA, USA) was coupled with the
TSQ mass spectrometer. The samples were loaded onto a
Luna 3 mm C18 column (4.6  150 mm, Phenomenex) with a
gradient of acetonitrile and water (containing 2 mM ammo-
nium acetate, pH 7.0) and a flow rate of 300 mL/min. The
gradient beganwith 3% acetonitrile for 10minutes followed by
a linear gradient up to 20% acetonitrile over the next 25 mi-
nutes. The samples were maintained at 5C in the autosam-
pler during the entire analysis.
Mass spectrometry. A TSQ Quantum Ultra Triple Stage
Quadrupole MS/MS System (ThermoFinnigan, San Jose, CA,
USA) was equipped with an atmospheric pressure ionization
electrospray (ES) interface. The instrument was operated in
positive ionmode. The sprayvoltagewas set to 3000V, vaporizer
temperature to 300C, and capillary temperature to 300C.
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Figure 6 e Electrospray positive ion/product ion mass spectra of 7-NAC-DHP from (A) organic synthesis; and in the
chromatographic peak eluting at 28.85e29.25 minutes in Fig. 5 obtained from the metabolism of monocrotaline in the
presence of N-acetylcysteine by (B) male human liver microsomes; and (C) male rat liver microsomes. The product ions of
the [M e H2O þ H]þ m/z 281 were acquired with a collision energy of 10 eV. DHP¼ (±)-6,7-dihydro-7-hydroxy-1-
hydroxymethyl-5H-pyrrolizine, NAC ¼ N-acetylcysteine.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4688Nitrogenwasusedas the sheath gas and the auxiliary gas; argon
was the collision gas. Nitrogen pressures of the sheath and
auxiliarygaseswereset to30and5 (arbitraryunits), respectively.
2.7. Quantitation of DHP-dG and DHP-dA adducts by
LC/MS/MS analysis
Liquid chromatography. A Finnigan Surveyor HPLC system
was coupled with the TSQ mass spectrometer. The samples
were loaded onto a reverse phase column (ACE 3 C18,
4.6 mm  150 mm, 3 mm; MACeMOD Analytical, Chadds Ford,
PA, USA) with a gradient of methanol and water (containing
2 mM ammonium acetate; pH 5) with a flow rate of 0.3 mL/
min. The gradient began with 15% methanol for 5 minutes,
followed by a linear gradient up to 65%methanol over the next
35 minutes. The samples were maintained at 5C in the
autosampler during the entire analysis.
Mass spectrometry. The same TSQ Quantum Ultra Triple
Stage Quadrupole ES-MS/MS System (ThermoFinnigan) was
used to perform for the DHP-DNA adduct analysis. The spray
voltage was 3000 V, vaporizer temperature was 400C, andcapillary temperature was 280C. Nitrogen pressure of sheath
and auxiliary gas was 30 and 5 (arbitrary units), respectively.
The argon collision gas pressure was 1.5 m Torr, the collision
energy was 17 eV for DHP-dG and its internal standard; and
21 eV for DHP-dA and its internal standard. The selected re-
action monitoring (SRM) scheme was employed involving
transitions of the [MþH]þ precursor ions to selected product
ions, with the following values: m/z 403 / 269 for DHP-dG
adducts; m/z 408/ 274 for DHP-[15N5]dG internal standards;
m/z 387/ 253 for DHP-dA adducts; m/z 402/ 263 for DHP-
[15N5,
13C10]dA internal standards.3. Results
3.1. Metabolism of riddelliine by human and rat liver
microsomes in the presence of N-acetylcysteine
The metabolism of riddelliine by male human liver micro-
somes in the presence of N-acetylcysteine was conducted and
the metabolites were separated by reversed-phase HPLC
R
el
at
iv
e 
ab
un
da
nc
e
R
el
at
iv
e 
ab
un
da
nc
e
R
el
at
iv
e 
ab
un
da
nc
e
Figure 7 e Electrospray positive ion/product ionmass spectra of DHP from (A) organic synthesis; and in the chromatographic
peak eluting at 25.3 minutes in Fig. 5 obtained from the metabolism of monocrotaline in the presence of N-acetylcysteine by
(B) male human liver microsomes; and (C) male rat liver microsomes. The product ions of the [M e H2O þ H]þm/z 136 were
acquired with a collision energy of 22 eV. DHP ¼ (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4 689(Fig. 2). The material in the two chromatographic peaks
eluting at 28.85e29.25 minutes (Fig. 2B) had HPLC retention
times, UV-visible-absorption spectra (data not shown), and
mass product ion scan profiles (Fig. 3B) identical to those of the
synthesized 7-NAC-DHP standard (Figs. 2A and 3A). The mass
product ion scan spectra of the 7-NAC-DHP synthetic standard
(Fig. 3A) and this metabolite (Fig. 3B) both had an
[MeH2OþH]þ ion atm/z 281 and characteristic fragment ions
at m/z 117e119, and m/z 151e152. Based on these spectral
results, the material eluting at 28.85e29.25 minutes in Fig. 2B
was unequivocally identified as 7-NAC-DHP. The chromato-
graphic peak eluting at 36.6 minutes in Fig. 2B was the
recovered riddelliine substrate.
The chromatographic peak eluting at 25.3 minutes (Fig. 2B)
had a HPLC retention time, UV-visible-absorption spectrum
(data not shown), and mass product ion scan profile (Fig. 4B)
identical to those of the DHP standard (Figs. 2A and 4A). The ES
positive product ionmass spectra had an [MeH2OþH]þ ion at
m/z 136 and the characteristic fragment ions at m/z 104e119
(Figs. 4AeD). Thus, the material eluting at 25.3 minutes in
Fig. 2B was unequivocally identified as DHP.The metabolism of riddelliine by male F344 rat liver mi-
crosomes in the presence of N-acetylcysteine was conducted
similarly. The HPLC profile is shown in Fig. 2C. Similar to the
description above for the metabolism of riddelliine by male
human liver microsomes, comparison of their HPLC retention
times, UV-visible absorption spectra (data not shown), and
mass spectra of the resulting metabolites with those of the
synthetic standards, the metabolites eluting at 25.3 minutes
and 28.85e29.25 minutes (Fig. 2C) were identified as DHP and
7-NAC-DHP, respectively.
The metabolism of riddelliine by male F344 rat liver micro-
somes in thepresence ofN-acetylcysteine and in the absence of
NADPH was conducted in parallel. As the metabolism result
shown in Fig. 2D and compared with metabolism in the pres-
ence of NADPH (Fig. 2C), the yields of both 7-NAC-DHP andDHP
decreased drastically in the absence of exogenous NADPH,
consistent with the requirement of NADPH as a cofactor for
cytochrome P450 enzyme activity. These results indicate that
the metabolic formation of 7-NAC-DHP was by the reaction of
dehydroriddelliine with N-acetylcysteine and that the forma-
tion of DHP is mainly by the hydrolysis of dehydroriddelliine.
Figure 8 e HPLC profiles of reactions of 7-NAC-DHP with dG and dA for 1, 3, and 5 days: (AeC) detection of DHP-dG adducts
monitored at 256 nm; and (DeF) detection of DHP-dA adducts monitored at 269 nm. For reaction conditions, see Materials
and methods section. dA ¼ 2′-deoxyadenosine, dG ¼ 2′-deoxyguanosine, DHP ¼ (±)-6,7-dihydro-7-hydroxy-1-
hydroxymethyl-5H-pyrrolizine.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 46903.2. Metabolism of monocrotaline by human and rat
liver microsomes
The metabolism of monocrotaline by male human and rat
liver microsomes in the presence of N-acetylcysteine was
conducted. Similar to the metabolism of riddelliine, the me-
tabolites were separated by HPLC (Figs. 5B and 5C) and iden-
tified by comparison of their HPLC retention times (Figs. 5B
and 5C), UV-visible absorption spectra (data not shown), andFigure 9 e The formation of DHP-dG and DHP-dA adducts
from reaction of 7-NAC-DHP with calf thymus DNA for 1, 3,
and 5 days. dA ¼ 2′-deoxyadenosine, dG ¼ 2′-
deoxyguanosine, DHP¼ (±)-6,7-dihydro-7-hydroxy-1-
hydroxymethyl-5H-pyrrolizine, NAC ¼ N-acetylcysteine.mass spectrometric profiles (Figs. 6 and 7) with those of the
synthetic standards. Both 7-NAC-DHP and DHP were similarly
identified.3.3. DHP-dG and DHP-dA adducts formed from reaction
of 7-NAC-DHP and dG and dA
The reaction of 7-NAC-DHP with dG was conducted for 1, 3,
and 5 days. At Day 1, DHP-dG-1 and DHP-dG-2 were formed
while DHP-dG-3 and DHP-dG-4 were not detected. At Day 3,
DHP-dG-3 and DHP-dG-4 were generated. At Day 5, DHP-dG-1
and DHP-dG-2 were formed as the predominant adducts (Figs.
8AeC). The reaction yields of DHP-dG-1 andDHP-dG-2 adducts
increased in a time dependent manner. The identity of the
DHP-dG products was confirmed by LC-MS/MS analysis and
compared with synthetic standards.
The formation of DHP was monitored at 220 nm by HPLC
and confirmed with the HPLC retention time and mass of the
authentic DHP. The yield of DHP was also increased in a time
dependent manner (data not shown).
Reaction of 7-NAC-DHP anddAwas similarly conducted. As
shown in Fig. 8DeF, the formation of DHP-dA-1 and DHP-dA-2
was faster than DHP-dA-3 and DHP-dA-4. On the basis of the
previous assumption that the molar extinction coefficients of
DHP-dA-1, DHP-dA-2, DHP-dA-3, and DHP-dA-4 are identical
[19], the yields of DHP-dA-1 and DHP-dA-2 are higher than
DHP-dA-3 andDHP-dA-4. Similar to the reactionof 7-NAC-DHP
with dG, DHP was also produced (data not shown).
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Figure 10 e LC/MS SRM chromatograms of DHP-dG and DHP-dA adducts formed from the reaction of 7-NAC-DHP with calf
thymus DNA for 3 days. dA ¼ 2′-deoxyadenosine, dG ¼ 2′-deoxyguanosine, DHP¼ (±)-6,7-dihydro-7-hydroxy-1-
hydroxymethyl-5H-pyrrolizine, IS ¼ DHP-[15N5]dG and DHP-[15N5, 13C10]dA labeled internal standards, LC/MS ¼ liquid
chromatography/mass spectrometry, NAC¼N-acetylcysteine, SRM ¼ selected reaction monitoring.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4 6913.4. LC-ES-MS/MS analysis of DHP-dG and DHP-dA
adducts formed from reaction of 7-NAC-DHP and calf
thymus DNA
The DHP-dG and DHP-dA adducts formed from reaction of 7-
NAC-DHP with calf thymus DNA in ammonium hydroxidesolution at pH 8 for 1, 3, and 5 days were quantitated by LC-ES-
MS/MS analysis using SRMmodewith the use of DHP-[15N5]dG-
3/4 and [15N5,
13C10]dA-3/4 as internal standards. At Day 1, all
theDHP-dG andDHP-dA adductswere formed (Fig. 9). At Day 5,
DHP-dA-1/2 was formed in the lowest yield. DHP-dA-3/4 ad-
ducts were the predominant adducts and their formation was
Figure 11 e The proposed general metabolic activation pathways leading to the formation of DNA adducts and the potential
initiation of PA-induced liver tumors. dA ¼ 2′-deoxyadenosine, dG ¼ 2′-deoxyguanosine, DHP¼ (±)-6,7-dihydro-7-
hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC¼N-acetylcysteine, PA ¼ pyrrolizidine alkaloids.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4692in a time-dependent manner. The representative LC/MS/MS
SRM chromatograms of the DHP-dG and DHP-dA adducts
formed from the reaction of 7-NAC-DHPwith calf thymus DNA
for 3 days are shown in Fig. 10. The results clearly indicate that
all of these DHP-dG and DHP-dA adducts were formed.4. Discussion
It has been established that the metabolism of PAs to the
reactive dehydro-PA metabolites is catalyzed by cytochrome
P-450 enzymes [6,15,29,30]. In order to exert the enzymatic
functions, cytochrome P-450 enzymes require NADPH as a
cofactor. In this study, we found that metabolism of riddel-
liine and monocrotaline by human and rat liver microsomes,
in the presence of N-acetylcysteine, generated 7-NAC-DHP.
However, its formation was inhibited when the metabolism
was conducted without the addition of NADPH. These results
clearly indicate that 7-NAC-DHP was formed through the re-
action of the dehydro-PA metabolite with N-acetylcysteine.
Although 7-NAC-DHP was found in the urine of rats admin-
istered monocrotaline or senecionine [28], our results show
for the first time that it is formed in the liver through the re-
action of dehydromonocrotaline or dehydrosenecionine with
7-N-acetylcysteine.
We also determined that 7-NAC-DHP is capable of binding
to deoxynucleic acids and calf thymus DNA. Reaction of 7-
NAC-DHP with dG formed DHP-dG-1, DHP-dG-2, DHP-dG-3,
and DHP-dG-4 adducts. Similarly, reaction with dA gener-
ated DHP-dA-1, DHP-dA-2, DHP-dA-3, and DHP-dA-4 adducts.
Furthermore, reaction of 7-NAC-DHP with calf thymus DNA
produced all the above-described DHP-dG and DHP-dA ad-
ducts (Figs. 9 and 10). These results indicate that 7-NAC-DHP is
a reactive liver microsomal metabolite capable of alkylating20-deoxynuclic acids, e.g., dG and dA, as well as DNA. This is
the first report to indicate that 7-NAC-DHP is a reactive
metabolite that can lead to DNA adduct formation.
We recently demonstrated that both 7-GS-DHP and 7-
cysteine-DHP can bind to DNA to form the same set of DNA
adducts [26,27]. To date, all the known metabolites that have
been shown to be capable of binding to DNA to form this set of
DNA adducts (DHP-dG-3, DHP-dG-4, DHP-dA-3, and DHP-dA-4
adducts) are dehydro-PAs, DHP, 7-GS-DHP, 7-cysteine-DHP,
and 7-NAC-DHP. This set of DHP-dG-3, DHP-dG-4, DHP-dA-3,
and DHP-dA-4 adducts has been proposed to be a biomarker
of PA exposure and potentially, a biomarker of PA-induced
liver tumorigenicity [8]. Thus, based on our findings, we pro-
pose that there exist multiple metabolic activation pathways
of carcinogenic PAs leading to the formation of pyrrolic DNA
adducts and causing PA-induced liver tumors initiation. These
proposed multiple activation pathways are illustrated in
Fig. 11.
N-Acetylcysteine, the N-acetyl derivative of the amino acid
L-cysteine, is a natural thiol-containing antioxidant and a
precursor for the synthesis of cysteine and glutathione in the
body. N-acetylcysteine, cysteine, and glutathione possess a
sulfhydryl (thiol) group that confers antioxidant effects to
scavenge free radicals generated in the body. Since N-ace-
tylcysteine, cysteine, and glutathione are commercial dietary
supplements, uptake of these antioxidants may increase the
formation of 7-N-acetylcysteine, 7-cysteine-DHP, and 7-
glutathione-DHP in humans who are exposed to PAs and
thus may cause adverse effects, which warrants further
investigation.
We have studied the synthesis, stability, solubility, and
reactivity of a series of secondary pyrrolic metabolites and
derivatives, including 7-NAC-DHP, 7-cysteine-DHP [27], 7-
glutathione-DHP [26], 7,9-diglutathione-DHP [31], and 7-
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 6 8 2e6 9 4 693valine-DHP [32]. We have determined that among these sec-
ondary pyrrolic metabolites, 7-NAC-DHP is less water soluble
and is relatively more stable. Thus, it is highly possible this
metabolite can be relatively easily translocated out of the liver
to other organs and exerts extrahepatic toxicity.Conflicts of interest
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